Savara, Inc. (SVRA)
5.02
-0.04
(-0.79%)
USD |
NASDAQ |
May 22, 16:00
5.12
+0.10
(+1.99%)
After-Hours: 20:00
Savara Total Liabilities (Quarterly) : 45.61M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 93.14M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Amgen, Inc. | 83.31B |
| Biogen, Inc. | 10.83B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 221.64M |
| Shareholders Equity (Quarterly) | 176.04M |
| Debt to Equity Ratio | 0.171 |
| Current Ratio | 13.47 |
| Net Debt Paydown Yield | -0.06% |